Medtech Innovation Isn't Dead, It's Just Different

> Download

The word "value" is invoked ever more frequently in relation to health care delivery, but it can mean different things depending on where you sit in the stakeholder chain. Health insurance companies and hospital systems naturally have different perspectives than device and drugmakers, and manufacturers are advised to track the changing market and focus on areas where they can make a difference.

ZS principals Brian Chapman and Bill Coyle share insights on the changing nature of innovation within the medtech industry in this IN VIVO article.